An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

12,046

Participants

Timeline

Start Date

October 1, 2011

Primary Completion Date

October 31, 2014

Study Completion Date

December 31, 2014

Conditions
Influenza
Interventions
BIOLOGICAL

Quadrivalent seasonal influenza vaccine(Flu D-QIV) GSK2321138A

Intramuscular injection

BIOLOGICAL

Havrix Junior

Intramuscular injection administered to subjects aged 12 months or older

BIOLOGICAL

Prevenar 13

Intramuscular injection administered to subjects less than 12 months of age

BIOLOGICAL

Varivax/ProVarivax

Intramuscular injection administered to subjects more than 12 months of age

BIOLOGICAL

Varilrix

Subcutaneous injection administered to subjects more than 12 months of age

Trial Locations (103)

1000

GSK Investigational Site, Dhaka

GSK Investigational Site, Manila

GSK Investigational Site, Metro Manila

1008

GSK Investigational Site, Sampaloc, Manila

1113

GSK Investigational Site, Quezon City

1200

GSK Investigational Site, Brussels

1600

GSK Investigational Site, Prague

1781

GSK Investigational Site, City of Muntinlupa

2018

GSK Investigational Site, Antwerp

2020

GSK Investigational Site, Antwerp

2300

GSK Investigational Site, Turnhout

2800

GSK Investigational Site, Mechelen

5000

GSK Investigational Site, Namur

8800

GSK Investigational Site, Roeselaere

10330

GSK Investigational Site, Bangkok

12004

GSK Investigational Site, Castellon

12530

GSK Investigational Site, Castellon

15706

GSK Investigational Site, Santiago de Compostela

17300

GSK Investigational Site, Blanes (Girona)

25070

GSK Investigational Site, Odolena Voda

28034

GSK Investigational Site, Madrid

28035

GSK Investigational Site, Madrid

28046

GSK Investigational Site, Madrid

28224

GSK Investigational Site, Pozuelo de Alarcón/Madrid

28250

GSK Investigational Site, Torrelodones (Madrid)

28660

GSK Investigational Site, Boadilla del Monte

28700

GSK Investigational Site, Madrid

29200

GSK Investigational Site, Antequera/Málaga

34890

GSK Investigational Site, Istanbul

37701

GSK Investigational Site, Jindřichův Hradec

40002

GSK Investigational Site, Khon Kaen

41014

GSK Investigational Site, Seville

41927

GSK Investigational Site, Seville

46011

GSK Investigational Site, Valencia

46015

GSK Investigational Site, Liberec

46024

GSK Investigational Site, Valencia

46200

GSK Investigational Site, Valencia

46702

GSK Investigational Site, Valencia

46800

GSK Investigational Site, Xativa/Valencia

46930

GSK Investigational Site, Quart de Poblet, Valencia

70800

GSK Investigational Site, Ostrava - Poruba

75131

GSK Investigational Site, Lipník nad Bečvou

121004

GSK Investigational Site, Faridabad

405 01

GSK Investigational Site, Děčín

396 01

GSK Investigational Site, Humpolec

547 01

GSK Investigational Site, Náchod

532 03

GSK Investigational Site, Pardubice

390 02

GSK Investigational Site, Tábor

Unknown

GSK Investigational Site, Santo Domingo

GSK Investigational Site, Santo Domingo, Distrito Nacional

GSK Investigational Site, San Pedro Sula

GSK Investigational Site, Tegucigalpa

GSK Investigational Site, Pune

GSK Investigational Site, Manila

GSK Investigational Site, Torun

GSK Investigational Site, Bursa

GSK Investigational Site, Eskişehir

411 011

GSK Investigational Site, Pune

1107-2020

GSK Investigational Site, Beirut

85-079

GSK Investigational Site, Bydgoszcz

85-168

GSK Investigational Site, Bydgoszcz

85-316

GSK Investigational Site, Bydgoszcz

39-200

GSK Investigational Site, Dębica

84-462

GSK Investigational Site, Gdansk

86-330

GSK Investigational Site, Grudziądz

40-018

GSK Investigational Site, Katowice

40-129

GSK Investigational Site, Katowice

31-223

GSK Investigational Site, Krakow

90-242

GSK Investigational Site, Lodz

20-044

GSK Investigational Site, Lublin

55-120

GSK Investigational Site, Oborniki

61-709

GSK Investigational Site, Poznan

62-064

GSK Investigational Site, Poznan

41-103

GSK Investigational Site, Siemianowice Śląskie

33-100

GSK Investigational Site, Tarnów

00-315

GSK Investigational Site, Warsaw

43-225

GSK Investigational Site, Wola

52-312

GSK Investigational Site, Wroclaw

21-010

GSK Investigational Site, Łęczna

08025

GSK Investigational Site, Barcelona

08042

GSK Investigational Site, Barcelona

08540

GSK Investigational Site, Centelles (Barcelona)

08500

GSK Investigational Site, Vic/ Barcelona

PL26 7RL

GSK Investigational Site, St Austell

SO16 6YD

GSK Investigational Site, Southampton

BS26 2BJ

GSK Investigational Site, Axbridge

BA1 3NG

GSK Investigational Site, Bath

BA21 4AT

GSK Investigational Site, Yeovil

CV9 1EU

GSK Investigational Site, Atherstone

CV6 4DD

GSK Investigational Site, Coventry

BT7 2EB

GSK Investigational Site, Belfast

BL3 6TL

GSK Investigational Site, Bolton, Nr Manchester

BS2 8AE

GSK Investigational Site, Bristol

BT41 3AE

GSK Investigational Site, Co Antrim

M8 9JT

GSK Investigational Site, Crumpsall, Manchester

EX2 5DW

GSK Investigational Site, Exeter

GL1 3NN

GSK Investigational Site, Gloucester

SW17 0QT

GSK Investigational Site, London

M13 9WL

GSK Investigational Site, Manchester

NG7 2QW

GSK Investigational Site, Nottingham

OX3 7LJ

GSK Investigational Site, Oxford

TA1 5DA

GSK Investigational Site, Taunton, Somerset

SE1 7EH

GSK Investigational Site, Westminster Bridge Road

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY